Anti-EGFR therapy

Epidermal growth factor receptor

Epidermal
The epidermal growth factor receptor (EGFR; ErbB-1; HER1 in humans) is the cell-surface receptor for members of the epidermal growth factor family (EGF-family) of extracellular protein ligands. The epidermal growth factor receptor is a member of the ErbB family of receptors, a subfamily of four closely related receptor tyrosine kinases: EGFR (ErbB-1), HER2/c-neu (ErbB-2), Her 3 (ErbB-3) and Her 4 (ErbB-4). Mutations affecting EGFR expression or activity could result in cancer. Epidermal Growth Factor was discovered by Stanley Cohen of Vanderbilt University along with Rita Levi-Montalcini for which both received the Nobel prize in Physiology or Medicine in 1986.

Anti-EGFR therapy - List of case studies

Treatments

Abundant hydration Acupuncture Acupuncture therapy Acupuncture treatment Adaptation training exercises ... incontinence procedure Anti reflux medication Anti-EGFR therapy Anti-HSV antibody Anti-HZV antibody Anti-MM ...

Multirelapse Squamed Carcinoma of the Skin

dose, followed by 250 mg/mq maintenance) - Symptomatic therapy: Omeprazen 20 mg 1 tablet; Medrol 16 mg 1/2 tablet x 2 (on a ... results from our study are encouraging and suggest that anti-EGFR therapy may have a role in the adjuvant treatment of HN cSCC . ...

JustAnswer.com